In human aortic smooth muscle cells, prostaglandin E 2 (PGE 2 ) stimulates adenylyl cyclase (AC) and attenuates the increase in intracellular free Ca 21 concentration evoked by activation of histamine H 1 receptors. The mechanisms are not resolved. We show that cAMP mediates inhibition of histamine-evoked Ca 21 signals by PGE 2 . Exchange proteins activated by cAMP were not required, but the effects were attenuated by inhibition of cAMP-dependent protein kinase (PKA). PGE 2 had no effect on the Ca 21 signals evoked by protease-activated receptors, heterologously expressed muscarinic M3 receptors, or by direct activation of inositol 1,4,5-trisphosphate (IP 3 ) receptors by photolysis of caged IP 3 . The rate of Ca 21 removal from the cytosol was unaffected by PGE 2 , but PGE 2 attenuated histamineevoked IP 3 accumulation. Substantial inhibition of AC had no effect on the concentration-dependent inhibition of Ca 21 signals by PGE 2 or butaprost (to activate EP 2 receptors selectively), but it modestly attenuated responses to EP 4 receptors, activation of which generated less cAMP than EP 2 receptors. We conclude that inhibition of histamine-evoked Ca 21 signals by PGE 2 occurs through "hyperactive signaling junctions," wherein cAMP is locally delivered to PKA at supersaturating concentrations to cause uncoupling of H 1 receptors from phospholipase C. This sequence allows digital signaling from PGE 2 receptors, through cAMP and PKA, to histamine-evoked Ca 21 signals.
Introduction
Ca 21 and cAMP are ubiquitous intracellular messengers that regulate most cellular behaviors. The versatility of these messengers depends on both the spatiotemporal organization of the changes in their concentration within cells (Cooper and Tabbasum, 2014) and on interactions between them [see references in Tovey et al. (2008) ]. These interactions are important in many smooth muscles, where increases in intracellular free Ca 21 concentration ([Ca 21 ] i ) stimulate contraction, but receptors that stimulate formation of cAMP usually cause relaxation. The clinical importance is clear from the widespread use of b-agonists to provide symptomatic relief from asthma (Morgan et al., 2014) . In vascular smooth muscle (VSM), too, cAMP attenuates the contractile responses mediated by many receptors that evoke Ca 21 signals (Morgado et al., 2012) . This inhibition is assumed to be mediated by cAMP-dependent protein kinase (PKA) (Murthy, 2006) , but there are also PKA-independent effects of cAMP (Spicuzza et al., 2001) . At least some of these effects may be through exchange proteins activated by cAMP (EPACs), probably EPAC 1, which is abundant in blood vessels particularly within endothelial cells (Roscioni et al., 2011) . Histamine and prostaglandin E 2 (PGE 2 ) are two important inflammatory mediators. Their effects on VSM, which include regulation of proliferation (Yau and Zahradka, 2003) and vascular tone (Toda, 1987; Jadhav et al., 2004) , are mediated by direct interactions with VSM and indirectly through release of autocrine signals from other cells (Norel, 2007) . Histamine, PGE 2 and their receptors are also implicated in vascular pathology, including inflammation (Norel, 2007) ABBREVIATIONS: AC, adenylyl cyclase; AKAP, A kinase-anchoring protein; ASMC, aortic smooth muscle cell; [Ca 21 ] i , intracellular free [Ca 21 ]; ci-IP 3 , D-2,3-O-isopropylidene-6-O-(2-nitro-4,5-dimethoxy)benzyl-myo-inositol 1,4,5-trisphosphate; ci-IP 3 PM, ci-IP3-hexakis(propionoxymethyl) ester; DDA, 29,59-dideoxyadenosine; EPAC, exchange protein activated by cAMP; [3] [4] [5] isoxazol-3-yl]-2-[2-(3-chlorophenyl)hydrazono]-3-oxopropanenitrile; HBS, HEPES-buffered saline; HJC0197, 4-cyclopentyl-2-(2,5-dimethylbenzylsulfanyl)-6-oxo-1,6-dihydropyrimidine-5-carbonitrile; H89, N-[2-[[3-(4-bromophenyl)-2-propenyl]amino]ethyl]-5-isoquinolinesulfonamide dihydrochloride; IBMX, 3-isobutyl-1-methylxanthine; IP 3 , inositol 1,4,5-trisphosphate; IP 3 R, IP 3 receptor; L902, 688 (5-[(1E,3R)-4,4-difluoro-3-hydroxy-4-phenyl-1-buten-1-yl]-1-[6-(2H-tetrazol-5R-yl)hexyl]-2-pyrrolidinone); NKH 477, (N, 4aR, 5S, 6aS, 10S, 10aR, 4a, 7, 7, pyran-6-yl ester b-alanine hydrochloride); PAR1, protease-activated receptor type 1; PDE, cyclic nucleotide phosphodiesterase; pIC 50 (pEC 50 ), negative logarithm of the half-maximally inhibitory (effective) concentration; PGE 2 , prostaglandin E 2 ; PKA, cAMP-dependent protein kinase; PKG, cGMP-dependent protein kinase; PKI (mut PKI), PKA inhibitor peptide (mutant inactive form); PLC, phospholipase C; SQ 22536, 9-(tetrahydro-2-furanyl)-9H-purin-6-amine; SQ/DDA, 1 mM SQ 22536 with 200 mM DDA; TBS, Tris-buffered saline; TBS-T, TBS with Tween; VASP, vasodilator-stimulated phosphoprotein; VSM, vascular smooth muscle.
atherosclerosis (Gómez-Hernández et al., 2006) , and restenosis (Sasaguri et al., 2005) .
We demonstrated previously that histamine, through H 1 receptors, stimulates an increase in [Ca 21 ] i in human aortic smooth muscle cells (ASMC). The initial response is mediated by Ca 21 release through inositol 1,4,5-trisphosphate receptors (IP 3 R) and it is followed by Ca 21 entry across the plasma membrane (Pantazaka et al., 2013 
Materials and Methods
Materials. H89, NKH 477, 8-Br-cAMP, and 8-Br-cGMP were from R&D Systems (Abingdon, Oxford, UK). Sp-cAMPS, 6-Bnz-cAMP, 8-pCPT-29-O-Me-cAMP, Rp-cAMPS, Rp-8-CPT-cAMPS, ESI-09, and HJC0197 were from Biolog (Bremen, Germany). Ionomycin, SQ 22536, DDA and myristoylated-PKA inhibitor peptide (PKI) were from Merck-Millipore (Watford, UK). A membrane-permeant peptide inhibitor of A kinase-anchoring proteins (AKAPs) [stearated Ht31 AKAP inhibitor peptide (st-Ht31)] and its proline-modified inactive form (st-Ht31P) were from Promega (Southampton, UK). Thapsigargin was from Alomone Laboratories (Jerusalem, Israel). PAR1 peptide, histamine dihydrochloride, forskolin, IBMX, and PGE 2 were from Sigma-Aldrich (Welwyn Garden City, UK). Butaprost (free acid) and L902,688 were from Cayman Chemicals (Ann Arbor, MI). Membranepermeant caged IP 3 (ci-IP 3 PM) was from SiChem (Bremen, Germany). [2, H] adenine ci-IP 3 PM, D-2,3-O-isopropylidene-6-O-(2-nitro-4,5-dimethoxy)benzyl-myo-inositol 1,4,5-trisphosphate-hexakis(propionoxymethyl) ester was from Perkin Elmer (Seer Green, Bucks, UK). Fluo-8 was from Stratech Scientific Ltd (Newmarket, Suffolk, UK). Other reagents were from Sigma-Aldrich, sources specified previously (Pantazaka et al., 2013) or identified in this section.
Culture of Human Aortic Smooth Muscle Cells. Human ASMC from the American Tissue Culture Collection (Manassas, VA) or Dr. Trevor Littlewood (Boyle et al., 2002) were cultured as described (Pantazaka et al., 2013) . Ethical approval for the latter was obtained from Addenbrooke's NHS Trust. Cells were derived from four Caucasian patients (males aged 23, 52, and 54, and a female aged 58), who died of causes unrelated to cardiovascular pathologies. Cells were used between passages two and six.
Measurements of [Ca 21 ] i . Histamine-evoked changes in [Ca 21 ] i were recorded from cell populations using confluent cultures of ASMC grown in 96-well plates and loaded with Fluo-4 or Fluo-8. Experiments were performed in HEPES-buffered saline (HBS) at 20°C. HBS had the following composition (mM): NaCl 135, KCl 5.9, MgCl 2 1.2, CaCl 2 1.5, glucose 11.5, and HEPES 11.6 (pH 7.3). Fluorescence was recorded using a FlexStation 3 fluorescence plate-reader (MDS Analytical Technologies, Wokingham, UK) and calibrated to [Ca 21 ] i as described (Pantazaka et al., 2013) .
For measurements of [Ca 21 ] i in single cells, confluent cultures of ASMC grown on poly-L-lysine-coated coverslips (22-mm diameter) were loaded with Fura-2 in HBS containing Fura-2 AM (4 mM), probenecid (2.5 mM), and pluronic F127 (0.02% v/v) for 1 hour at 20°C. Fluorescence (detected at .510 nm with alternating excitation at 340 and 380 nm) was recorded using an Olympus IX71 inverted fluorescence microscope and Luca (electron-multiplying chargecoupled device) EMCCD Andor Technology, Belfast, UK camera. After correction for background fluorescence, determined by addition of ionomycin (1-5 mM) in HBS containing MnCl 2 (1 mM), fluorescence ratios (F 340 /F 380 ) were calibrated to [Ca 21 ] i (Tovey et al., 2003 (Pantazaka et al., 2013) .
Expression of PKI and M3 Muscarinic Receptors. Plasmids encoding PKI (pRSV-PKI-v2) and its inactive form (pRSV-mut PKI-v2) were from Addgene (cat. no. 45066 and cat. no. 45067; Cambridge, MA) (Day et al., 1989) ; they were C-terminally tagged with mCherry. Plasmid encoding the human M3 muscarinic acetylcholine receptor was from the cDNA Resource Centre (cat. no. MAR0300000) (Ford et al., 2002) . The three constructs were each recombined into BacMam pCMV-DEST. Bacmids were then prepared, and virus was produced from bacmid-infected Sf9 cells according to the manufacturer's instructions (Thermo Fisher Scientific, Runcorn, UK). ASMC were infected at a multiplicity of infection (MOI) of ∼50 and used after 96 hours.
Flash Photolysis of Caged IP 3 . Confluent cultures of ASMC grown on poly-L-lysine-coated imaging dishes (35-mm diameter with a 7-mm glass insert; MatTek Corporation, Ashland, MA) were loaded (45 minutes, 20°C) with a membrane-permeant form of caged IP 3 (ci-IP 3 PM, 1 mM) in HBS with probenecid (2.5 mM) and pluronic F127 (0.02% v/v). Fluo-4 AM (4 mM) was then added and after 45 minutes at 20°C, the medium was replaced with HBS containing only probenecid. After a further 45 minutes, this medium was replaced with HBS. Cells were illuminated with a 488-nm diodebased solid-state laser, and emitted fluorescence (500-550 nm) was captured with an EMCCD camera. Three UV flashes (each ∼1-millisecond duration; ,345 nm, 3000 mF, 300 V, ∼170 J) from a JML-C2 Xe flash-lamp (Rapp OptoElectronic, Hamburg, Germany) allowed photolysis of caged IP 3 (ci-IP 3 ). Responses are reported as F/F 0 , where F 0 and F are fluorescence intensities corrected for background recorded from the same region of interest immediately before (F 0 ) and after stimulation (F).
Measurements of IP 3 and PLC Activity. ASMC in 12-well plates were cultured until confluent. The medium was then supplemented with D-myo-[2-3 H]-inositol (10 mCi/ml) for 48 hours at 37°C. After washing, cells were incubated at 20°C in HBS with LiCl (10 mM) for 5 minutes before stimulation. Reactions were terminated by aspirating medium and adding cold HClO 4 (1 ml, 0.6 M) containing phytic acid (0.2 mg/ml). After 30 minutes, the acid-extract was removed, the cells were scraped into 50 mM Tris at pH 7 (400 ml), and the pooled extract and cells were centrifuged (10,000g, 2 minutes, 4°C). The supernatant was neutralized using K 2 CO 3 (1 M) with EDTA (5 mM). H-inositol phosphates were separated using ion-exchange columns.
For assays of IP 3 mass, ASMC in 75-cm 2 flasks were stimulated, the medium was removed, and the incubations were terminated by scraping cells into ice-cold ethanol (1 ml). After 30 minutes, extracts were dried and suspended in 300 ml of Tris-EDTA medium (TEM: 50 mM Tris, 1 mM EDTA, pH 8.3). Equilibrium-competition binding using 3 H-IP 3 (4.5 nM, 19.3 Ci/mmol), rat cerebellar membranes (10 mg) and cell extract (20-100 ml) in a final volume of 200 ml of TEM was used to determine the IP 3 content of the extracts (Rossi et al., 2009 Immunoblotting. Confluent ASMC in 75-cm 2 flasks or six-well plates were stimulated and then scraped into cold phosphate-buffered saline supplemented with Triton-X-100 (1% w/v), protease inhibitors (one mini-tablet per 10 ml; Roche Applied Science, Burgess Hill, UK), and phosphatase inhibitors (10 ml/ml; Sigma-Aldrich). Scraped cells were disrupted by ∼30 passages through a 28-gauge needle and sonicated (3 Â 10 seconds). Proteins were separated by SDS-PAGE (NuPAGE 4%-12% Bis-Tris gels; Invitrogen, Paisley, UK) and transferred to a polyvinylidene difluoride membrane (iBlot; Invitrogen). Membranes were washed (5 minutes) with Tris-buffered saline (TBS: 137 mM NaCl, 20 mM Tris, pH 7.6), blocked by incubation in TBS containing 0.1% Tween-20 (TBS-T) and 5% (w/v) nonfat milk powder (1 hour, 20°C), and then washed with TBS-T (3 Â 5 minutes). Blots were incubated for 12 hours at 4°C with primary antibody (1:1000) in TBS-T with 5% (w/v) BSA. After washing (3 Â 5 minutes), blots were incubated with horseradish peroxidase-conjugated donkey anti-rabbit secondary antibody (1:2000; Santa Cruz Biotechnology, Dallas, TX) for 1 hour in TBS-T with 5% (w/v) nonfat milk powder. After further washing (3 Â 5 minutes), bands were detected using ECL Prime (GE Healthcare, Chalfont St Giles, UK) and quantified using GeneTools (Syngene, Cambridge, UK). The primary rabbit antibodies recognize PKA-phosphorylated sequences RXXS*/T* (AbP1, AbP2, cat. nos. 9621 and 9624; New England Biolabs, Hitchin, UK; * denotes the phosphorylated residue) and vasodilator-stimulated phosphoprotein (VASP [clone 43, BD Biosciences, San Jose, CA]) phosphorylated at Ser-157 (New England Biolabs) or VASP clone 43 (BD Biosciences, San Jose, CA).
Quantitative PCR Analysis. QPCR was performed as described (Tovey et al., 2008) using primers specific for AC subtypes (Ludwig and Seuwen, 2002) and calibrated against expression of the housekeeping gene, glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (Pantazaka et al., 2013) . Human BioBank cDNA pooled from a variety of tissues (Primerdesign, Southampton, UK) was used as a positive control for AC subtypes not expressed in ASMC.
Statistical Analysis. Concentration-effect relationships were individually fitted by nonlinear curve-fitting to Hill equations (GraphPad Prism, La Jolla, CA). The absolute sensitivities and amplitudes of the responses to histamine and PGE 2 varied between patients and with cell passage. Results are, therefore, often presented as normalized values (e.g., as percentages of a maximal response) or as differences between paired comparisons (e.g., DpIC 50 ). Two-tailed paired or unpaired Student's t test, or oneway analysis of variance followed by Bonferroni's test, were used as appropriate.
Results
Cyclic AMP Mediates Inhibition of HistamineEvoked Ca 21 Signals by PGE 2 . Figure 1A demonstrates that PGE 2 inhibits the Ca 21 signals evoked by histamine in human ASMC. Most experiments were performed at 20°C to minimize loss of the cytosolic Ca 21 indicator. However, in parallel analyses we confirmed that a maximally effective concentration of PGE 2 (10 mM) caused indistinguishable inhibition of the Ca 21 signals evoked by histamine (100 mM) whether the analyses were performed at 20°C (47% 6 12% inhibition, n 5 4) or 37°C (45% 6 6%). In parallel measurements of the effects of PGE 2 on intracellular cAMP and histamine-evoked Ca 21 signals, the cAMP response [negative logarithm of the half-maximally effective concentration (pEC 50 ) 5 6.76 6 0.09, n 5 4) was ∼140-fold less sensitive to PGE 2 than were the Ca 21 signals [negative logarithm of the half-maximally inhibitory concentration (pIC 50 ) 5 8.90 6 0.10, n 5 6] (Fig. 1B) . This relationship is consistent with PGE 2 evoking formation of more cAMP than needed to maximally inhibit Ca 21 signals, and with cAMP lying upstream of the inhibition of Ca 21 signaling (Strickland and Loeb, 1981) .
Forskolin and its water-soluble analog, NKH 477, directly activate eight of the nine membrane-bound forms of AC (AC1-8) (Seifert et al., 2012) . Pretreatment of ASMC with NKH 477 caused a concentration-dependent reduction in both the peak amplitudes of the Ca 21 signals evoked by histamine and their sensitivity to histamine ( Fig. 1C ; Table 1 ). Similar results were obtained with forskolin (Fig. 1D) . Maximally effective concentrations of PGE 2 and NKH 477 caused indistinguishable inhibition of histamine-evoked Ca 21 signals, and their combined maximal effects were not additive (Fig. 1E) . These results are consistent with reports showing that forskolin and NKH 477 attenuate the Ca 21 signals evoked by receptors, including H 1 receptors that stimulate PLC in VSM (Yang et al., 1999 , and references therein) and other smooth muscles. There has, however, been no prior demonstration that activation of AC inhibits PLC-evoked Ca 21 signals in human ASMC.
High concentrations of 8-Br-cAMP also inhibited histamineevoked Ca 21 signals by reducing the maximal response and the sensitivity to histamine ( Fig. 2A) . 8-Br-cAMP had no effect on the Ca 21 content of the intracellular stores (Fig. 2B) . The effects of 8-Br-cAMP were mimicked by Sp-cAMPS, which activates PKA and EPACs, and by 6-Bnz-cAMP and 8-CPT-6-Phe-cAMP, which activate PKA but not EPACs ( Fig. 2C ; Supplemental Fig. S1 ; and Table 1) . A high concentration (10 mM) of 8-pCPT-29-O-Me-cAMP, a membrane-permeant activator of EPACs; and Rp-cAMPS and Rp-8-CPT-cAMPS, antagonists of both PKA and EPACs, were ineffective ( Fig. 2D ; Supplemental Fig. S1 ).
The negative result with 8-pCPT-29-O-Me-cAMP is important because this analog is more membrane-permeable than 8-Br-cAMP, and it both binds with greater affinity than cAMP to EPACs and more effectively activates them (Gloerich and Bos, 2010) . Furthermore, antagonists of EPACs 1 and 2, HJC0197 (Chen et al., 2012) , and ESI-09 (Almahariq et al., 2013) (Meena et al., 2015) . Others have also reported nonspecific effects of these EPAC antagonists (Rehmann, 2013) .
Maximally effective concentrations of PGE 2 , forskolin, NKH 477, or 8-Br-cAMP similarly attenuated the Ca 21 signals evoked by histamine, and combinations of the treatments were not additive (Fig. 2D) . These results establish that inhibition of histamine-evoked Ca 21 signals by PGE 2 is mediated by cAMP (Fig. 2F) signals evoked by a submaximal concentration of histamine, but the maximal inhibition was less than half that evoked by PGE 2 or 8-Br-cAMP (Fig. 3, A and B) . Furthermore, and in contrast to the effects of 8-Br-cAMP (Fig. 2C) , 8-Br-cGMP did not inhibit the Ca 21 signals evoked by a maximal histamine concentration (Fig. 2D ). Prolonged incubation with IBMX (20 minutes, 1 mM), a nonselective inhibitor of PDEs, inhibited histamine-evoked Ca 21 signals, but the inhibition (33% 6 3%, n 5 4) was less than that caused by PGE 2 (56% 6 3%) (Fig. 3C) . More importantly, a maximal concentration of PGE 2 similarly inhibited histamine-evoked Ca 21 signals in ) or stimulation (cAMP), are means 6 S.E.M. from six and four experiments, respectively. This panel includes some data for cAMP measurements that were published previously (Pantazaka et al., 2013) . (C) Effect of NKH 477 (100 mM) on the peak Ca 2+ signal evoked by histamine. (D) Concentration-dependent effects of forskolin on the peak Ca 2+ signals evoked by histamine (1 mM). (E) Effect of PGE 2 (10 mM), NKH 477 (100 mM), or both on the peak Ca 2+ signals evoked by histamine (as percentages of the maximal response). NKH 477, forskolin, or PGE 2 were added 5 minutes before and then during stimulation with histamine. Results show means 6 S.E.M. from four (C and D) or three (E) independent plates with one to three wells analyzed from each. Ct denotes control. . Results (as percentages of the response to histamine alone) are means 6 S.E.M. from three experiments with two to three wells in each. Results for Rp-cAMPS are from a single experiment with three replicates, limited by the availability of this expensive analog. (E) Effects of the EPAC antagonists, ESI-09 and HJC0197 (10 mM, 20 minutes), on the Ca 2+ signals evoked by histamine (3 mM) added 5 minutes before and then during treatment with the indicated concentrations of PGE 2 . Results are expressed as percentages of the paired response to histamine alone (means 6 S.E.M., n = 3-5; n = 2 for the antagonists with 1 and 3 nM PGE 2 , where error bars show ranges). (F) The results establish that cAMP mediates inhibition of histamine-evoked Ca 2+ signals by PGE 2 .
Inhibition of Ca 21 Signals by cAMP Signaling Junctions
The latter cannot mediate the effects of cAMP on IP 3 -evoked Ca 21 release, nor are EPACs responsible. We therefore assessed the role of PKA.
Immunoblotting with an antiserum that recognizes sequences phosphorylated by PKA showed that maximally effective concentrations of PGE 2 or 8-Br-cAMP stimulated similar levels of protein phosphorylation in ASMC and their effects were nonadditive (Fig. 4A) . The phosphorylation was mimicked by 6-Bnz-cAMP but not by the EPAC-selective analog 8-pCPT-29-O-Me-cAMP (Fig. 4A) . PGE 2 -evoked protein phosphorylation was attenuated by inhibition of either PKA (with H89) or AC [with 1 mM SQ 22536 with 200 mM DDA (SQ/DDA)] (Fig. 4B) .
Maximal concentrations of PGE 2 and 8-Br-cAMP caused phosphorylation of the same proteins (Fig. 4A ), but the two stimuli differed in their susceptibility to PKA inhibitors. Rp-8-CPT-cAMPS, an inhibitor of PKA that competes with cAMP by binding to the regulatory subunit of PKA, abolished the phosphorylation evoked by 8-Br-cAMP but only partially inhibited that evoked by PGE 2 (Fig. 4C) . Conversely, H89, which inhibits PKA (and other kinases) by competing for the ATP-binding site, abolished the phosphorylation evoked by PGE 2 but caused lesser inhibition of the response to 8-Br-cAMP (Fig. 4C) . Similar results were obtained when an antiserum to phospho-VASP was used to assess PKAmediated phosphorylation (Supplemental Fig. S2 ).
These results suggest that PKA activated by PGE 2 may be exposed to high local concentrations of cAMP, which might then effectively compete with the inhibitor Rp-8-CPT-cAMPS. Conversely, PKA activated by 8-Br-cAMP, which would probably be uniformly distributed within the cell, may be more accessible to ATP than PKA activated by PGE 2 , and so less susceptible to inhibition by H89.
Inhibition of Histamine-Evoked Ca 21 Signals by PGE 2 Is Attenuated by Inhibition of PKA. Inhibition of histamine-evoked Ca 21 signals by PGE 2 or 8-Br-cAMP was inhibited by Rp-8-CPT-cAMPS (1 mM), which reduced the sensitivity to PGE 2 (decreasing the pIC 50 for PGE 2 from 8.68 6 0.17 to 8.26 6 0.05, n 5 3; DpIC 50 5 0.4 6 0.1, where DpIC 50 5 pIC 50 control -pIC 50 Rp-8-CPT-cAMPS ) and 8-Br-cAMP (DpIC 50 5 0.6 6 0.1) without affecting the maximal inhibition (Fig. 5, A  and B) . These results are consistent with Rp-8-CPT-cAMPS competitively inhibiting cAMP binding to PKA and thereby attenuating the effects of cAMP on Ca 21 signals. H89 (10 mM) also attenuated the inhibition of histamineevoked Ca 21 signals by 8-Br-cAMP (DpIC 50 5 1.13 6 0.18 n 5 3) and PGE 2 (Fig. 5, A and B) . In keeping with our analyses of protein phosphorylation (Fig. 4C) , the inhibition of histamine-evoked Ca 21 signals by maximal concentrations of PGE 2 were less effectively inhibited by H89 than were the effects of maximal concentrations of 8-Br-cAMP (compare Fig. 5, A and B) .
PKI inhibits PKA by competing with its peptide substrates. We could not achieve effective inhibition of PKA-mediated protein phosphorylation with myristoylated-PKI (10 mM, 20 minutes, data not shown). But using a baculovirus, we achieved expression of PKI in .90% of cells, and this caused 49% 6 6% (n 5 3) inhibition of the VASP phosphorylation evoked by PGE 2 (100 nM) (Supplemental Fig. S3 ). Expression of an inactive PKI (mut PKI) had no effect on PGE 2 -evoked protein phosphorylation (Supplemental Fig. S3 ). The effects of H89 and PKI on the inhibition of histamine-evoked 
Ca
21 signals by PGE 2 were similar: Each substantially reduced the maximal inhibition without significantly affecting the IC 50 for PGE 2 (Fig. 5, A and C) . The effects of H89 on inhibition of histamine-evoked Ca 21 signals by selective agonists of EP 2 (butaprost) and EP 4 (L902,688) receptors were similar to those observed with PGE 2 (Supplemental Fig. S4 ). We conclude that inhibition of histamine-evoked Ca 21 signals by PGE 2 is mediated by cAMP and requires PKA (Fig. 5D) .
PGE 2 Does Not Inhibit Ca 21 Release Evoked by Direct Activation of IP 3 Rs. The rate at which [Ca 21 ] i recovered from the peak Ca 21 signal evoked by histamine was unaffected by PGE 2 (half-times for recovery were 19 6 1 and 17 6 1 seconds, after histamine alone or with PGE 2 , respectively; n 5 11) (Supplemental Fig. S5 ). This suggests that the attenuated Ca 21 signals do not result from PGE 2 stimulating Ca 21 extrusion from the cytosol. We used flash-photolysis of ci-IP 3 to activate IP 3 R directly in Fluo-4-loaded ASMC. Single-cell analyses of ASMC established that most cells (99% 6 1%, from 12 fields) responded to histamine (1 mM) with an increase in [Ca 21 ] i , and that two successive challenges with histamine evoked indistinguishable Ca 21 signals (Fig. 6, A and B) . PGE 2 reduced the peak amplitude of the Ca 21 signal evoked by a second histamine challenge by 28% 6 4% (n 5 65 cells), without significantly affecting the number of cells that responded (91% 6 8% and 83% 6 7% for control and PGE 2 -treated cells, respectively) (Fig. 6, C and D) . These results confirm that under the conditions used for uncaging ci-IP 3 , PGE 2 inhibits histamineevoked Ca 21 signals. ASMC loaded with ci-IP 3 responded to UV flashes with rapid increases in Fluo-4 fluorescence (F/F 0 , see Materials and Methods). The amplitudes of these signals were less than those evoked by a maximal concentration of histamine (Fig. 6 , E and F), confirming that responses to photolysis of ci-IP 3 were not saturated. Although cells responded similarly to successive histamine challenges (Fig. 6, A and B) , the response to a second photolysis of ci-IP 3 was smaller than the first (Fig. 6G) , presumably because each stimulus depleted a fraction of the ci-IP 3 . We therefore used two methods to assess the effects of PGE 2 on the Ca 21 signals evoked by photolysis of ci-IP 3 . Cells were either stimulated twice with a UV stimulus, and the amplitude of the second response (with or without PGE 2 ) was compared with the first response for each cell (R2/R1) (Fig. 6 , G-I), or cells were stimulated once with UV flashes alone or in the presence of PGE 2 (Fig. 6J) . Both analyses concur in demonstrating that PGE 2 has no significant effect on the Ca 21 signals evoked by IP 3 (Fig. 6, G-J) . The results with ci-IP 3 therefore demonstrate that PGE 2 does not affect the (Fig.  6, I and J), the results provide additional evidence that PGE 2 does not stimulate Ca 21 removal from the cytosol. The product of ci-IP 3 photolysis is an active but modified form of IP 3 (D-2,3-O-isopropylidene-myo-inositol 1,4,5-trisphosphate) (Dakin and Li, 2007) that is not a substrate for IP 3 3-kinase and may differ from IP 3 in its rate of dephosphorylation. Our results do not therefore exclude the possibility that PGE 2 may accelerate degradation of IP 3 . These results suggest that PGE 2 attenuates histamine-evoked Ca 21 signals by inhibiting IP 3 formation, stimulating IP 3 degradation, and/or disrupting IP 3 delivery to IP 3 Rs.
PGE 2 Attenuates Histamine-Evoked Accumulation of IP 3 . Using an assay that reports PLC activity (stimulation after blocking inositol monophosphate degradation by Li 1 ), histamine (1 mM, 30 minutes) stimulated a small accumulation of 3 H-inositol phosphates in ASMC. Although the response was modestly attenuated by PGE 2 (10 mM), the effect was not statistically significant (Fig. 7A) . Using an IP 3 R-based bioassay that detects only (1,4,5)IP 3 , histamine stimulated IP 3 accumulation, and the response was attenuated by PGE 2 , although the latter again failed to achieve statistical significance (Fig. 7B) . We also attempted to measure histamine-evoked IP 3 formation in single cells using a fluorescence resonance energy transfer (FRET)-based IP 3 sensor (Gulyas et al., 2015) , but the signals were too small to resolve reliably any inhibitory effect of PGE 2 . Available genetically encoded IP 3 sensors are known to have limited dynamic range and limited capacity to resolve small changes in intracellular IP 3 concentration (Miyamoto and Mikoshiba, 2017) .
We assessed the responses of ASMC to other stimuli (ATP, bradykinin, carbachol, phenylephrine, and thrombin) that might be expected to evoked Ca 21 signals through receptors that stimulate Gq (results not shown). Only thrombin reproducibly evoked substantial increases in [Ca 21 ] i . Thrombin is a protease that cleaves the type 1 protease-activated receptor (PAR1) to unmask an N-terminal ligand. Thrombin and the PAR1 peptide itself evoked concentration-dependent increases in [Ca 21 ] i in ASMC (Fig. 7C) . In parallel analyses, PGE 2 (10 mM, 5 minutes) attenuated the Ca 21 signals evoked by histamine without affecting those evoked by PAR1 peptide (Fig. 7D) . Although the maximal increase in [Ca 21 ] i evoked by PAR1 peptide was larger than that evoked by histamine, with concentrations of histamine and the PAR1 peptide that evoked comparable increases in [Ca 21 ] i , only the response to histamine was inhibited by PGE 2 (Fig. 7E) . After heterologous expression of human muscarinic M3 acetylcholine receptors in ASMC, carbachol evoked a concentration-dependent (pEC 50 5 7.72 6 0.04, n 5 3) increase in [Ca 21 ] i , with a maximal increase (272 6 31 nM, n 5 3) comparable to that evoked by histamine (204 6 13 nM, Fig. 2A) . However, the responses to carbachol were unaffected by PGE 2 (Fig. 7F) . These results, demonstrating that PGE 2 selectively inhibits the Ca 21 signals evoked by histamine, suggest that the inhibition probably does not arise downstream of PLC. 
Inhibition of Ca 21 Signals by cAMP Signaling Junctions
Histamine-Evoked Ca 21 Signals Are Inhibited by Local cAMP Signals. Inhibitors of AC (SQ/DDA) attenuated PGE 2 -evoked cAMP formation (by 79% 6 2%, n 5 4) (Fig. 8A ) and protein phosphorylation (Fig. 4B) . However, SQ/DDA had no effect on the inhibition of histamine-evoked Ca 21 signals evoked by PGE 2 or butaprost (Fig. 8, B and C). Although cAMP mediates the inhibition of Ca 21 signals by PGE 2 , the response to a maximal concentration of PGE 2 might survive substantial inhibition of AC because it stimulates formation of more cAMP than needed to maximally inhibit Ca 21 signals (Fig. 1B) . However, the same argument cannot account for the lack of effect of SQ/DDA on responses to submaximal concentrations of PGE 2 . How might a submaximal response to PGE 2 be unaffected by substantial inhibition of cAMP formation and PKA activity ( Fig. 4B; Fig. 8, A and B) ?
A possible explanation is that SQ 22356 and DDA, related inhibitors that bind to the ATP-binding site of AC (Brand et al., 2013) , selectively inhibit subtypes of AC distinct from those that mediate the effects of PGE 2 . Available antibodies do not allow quantitative assessment of the expression of AC -free HBS with the indicated concentrations of carbachol alone or with PGE 2 (10 mM, 5 minutes). Results are means 6 S.E.M., n = 3, with six replicates for each. There was no response to carbachol in normal ASMC (data not shown).
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subtypes, but QPCR analysis shows that human ASMC express similar amounts (∼30%) of AC3, AC7, AC9, some AC6 (∼10%), and detectable AC4 (∼2%) (Supplemental Fig. S6 ). AC9 probably does not mediate the effects of PGE 2 on Ca 21 signals because AC9 is insensitive to forskolin and NKH 477 (Seifert et al., 2012) , which mimic the effects of PGE 2 on Ca 21 signals (Fig. 1, C-E; Fig. 2D ). Among the remaining ACs expressed in ASMC, SQ22536 and DDA probably have some selectivity for AC6 over AC3 and AC7 despite some inconsistent reports (Pierre et al., 2009; Seifert et al., 2012) . From analyses of individual AC isoforms, maximally effective concentrations of SQ 22356 (and other P-site inhibitors) inhibit catalytic activity by only ∼80% [Brand et al. (2013) , but see Onda et al. (2001) ]. This is similar to the ∼80% inhibition of PGE 2 -evoked cAMP accumulation by SQ/DDA in ASMC (Fig. 8A) , suggesting that the incomplete inhibition observed in ASMC probably does not reflect the unperturbed activity of SQ/DDA-insensitive ACs. Furthermore, the effects , respectively, inhibits histamine-evoked Ca 2+ signals, but the latter evokes formation of less cAMP. We propose, from our results with SQ/DDA, that cAMP is locally delivered to PKA within each signaling junction at a concentration more than sufficient to cause a maximal effect. The concentration-dependent inhibition of Ca 2+ signals by prostanoids is proposed to result from recruitment of all-or-nothing cAMP signaling junctions, rather than from graded increases in activity within individual junctions. EP 2 receptors deliver more cAMP than EP 4 receptors and are therefore more resistant to inhibition of AC by SQ/DDA. Hence inhibition of Ca 2+ signals by EP 4 receptors is partially inhibited by SQ/DDA, whereas the response to EP 2 receptors is insensitive (right). *P , 0.05, paired Student's t-test relative to control.
Inhibition of Ca
21 Signals by cAMP Signaling Junctions of PGE 2 on protein phosphorylation in ASMC are inhibited by SQ/DDA (Fig. 4B) , again suggesting that the ACs activated by PGE 2 are inhibited. We conclude that the lack of effect of SQ/DDA on PGE 2 -mediated inhibition of histamine-evoked Ca 21 signals is probably not the result of ineffective inhibition of an SQ/DDA-resistant subtype of AC.
To account for the results with SQ/DDA, we suggest that cAMP is delivered locally to PKA at concentrations more than sufficient to fully inhibit Ca 21 signals. The concentrationdependent effects of PGE 2 might then result from recruitment of these "hyperactive" cAMP signaling junctions, rather than from increased activity within individual junctions (Fig. 8F) (Pantazaka et al., 2013) . This suggests that EP 4 receptors may less effectively saturate the cAMP signaling junctions. Whereas inhibition of AC with SQ/DDA had no effect on the inhibition of histamine-evoked Ca 21 signals by PGE 2 or butaprost (to selectively activate EP 2 receptors), the sensitivity to L902,688, a selective agonist of EP 4 receptors, was modestly reduced by SQ/DDA (DpIC 50 5 0.32 6 0.10, n 5 5) (Fig. 8, B-E ). This observation supports our suggestion that the subtype(s) of AC that link prostanoid receptors to inhibition of Ca 21 signals are sensitive to SQ/DDA. Furthermore, these results are consistent with the scheme shown in Fig. 8F , where we suggest that cAMP is locally delivered within "hyperactive" signaling junctions at concentrations more than sufficient to maximally activate the PKA that inhibits Ca 21 signals. We considered whether AKAPs, which are widely implicated in assembling PKA with its regulators and effectors (Smith et al., 2017) , might contribute to organization of the cAMP signaling through PKA that leads to inhibition of histamine-evoked Ca 21 signals. A membrane-permeant peptide that disrupts association of AKAPs with PKA (st-Ht31) but not its inactive analog (st-Ht31P), significantly attenuated the protein phosphorylation evoked by PGE 2 , but neither peptide affected the concentration-dependent inhibition of histamine-evoked Ca 21 signals by PGE 2 (Supplemental Fig.  S7 ). These results suggest that AKAPs are probably not important components of the signaling pathway from PGE 2 to inhibition of Ca 21 signals.
signaling from receptors to intracellular targets via hyperactive junctions (Fig. 8F ) allows robust and reliable communication, and may be a general feature of signaling by diffusible intracellular messengers (Tovey et al., 2008) .
